Navigation Links
Hunt for human genes involved in cell division under way

A systematic search through human genes has begun at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany. Working within the MitoCheck consortium that includes 10 other institutes throughout Europe, the EMBL scientists will silence all human genes, one-by-one, to find those involved in cell division (mitosis) and to answer fundamental questions of how cell division is regulated.

The scientists will use a method called 'RNA interference (RNAi)' where chemically synthesized RNA molecules are used to target and silence each human gene. About 22,000 genes will be suppressed and their impact on cell division monitored by live cell microscopy to understand each gene's role in cell division.

"To our knowledge, we are the first group to take on this systematic search through the genome in live cells. We will use the most potent RNAi reagent for this study, which is usually out of reach for academic labs because of the enormous cost and the ever-changing annotation of the human genome. But being part of the large EU project MitoCheck allowed us to work with one of the leading suppliers of siRNAs, Ambion Europe, Ltd., to produce a genome-wide library for this project," says Dr. Jan Ellenberg, EMBL Group Leader and co-initiator of the MitoCheck project.

Undertaking such a large project required tens of thousands of siRNA molecules, as two to three molecules are targeted specifically against each human gene. EMBL chose Ambion as a supplier of the siRNA library because its library could be tailored to the most up-to-date list of human target genes ?a list provided by the Wellcome Trust Sanger Institute, the MitoCheck bioinformatics partner. Also, Ambion's siRNA libraries utilize a siRNA design algorithm developed by Cenix BioScience GmbH (an EMBL spin-off company), leading to high efficacy of the siRNAs.

"We are happy to work with Ambion and Cenix BioScience on this ambitious project. This represents the first use of a genome-wi
'"/>

Source:European Molecular Biology Laboratory


Page: 1 2

Related biology news :

1. Novel technology detects human DNA mutations
2. Current human embryonic stem cell lines contaminated UCSD/Salk team finds
3. UWs Rosetta software to unlock secrets of many human proteins
4. Genome-wide mouse study yields link to human leukemia
5. Found: Missing sequence of the human Y chromosome
6. Study finds more than one-third of human genome regulated by RNA
7. Molecular machine may lead to new drugs to combat human diseases
8. Sea skate experiment sheds light on human cell transport
9. Mouse brain tumors mimic those in human genetic disorder
10. Zebrafish may hold key to understanding human nerve cell development
11. Yale researchers identify molecule for detecting parasitic infection in humans
Post Your Comments:
(Date:12/3/2009)... WALL, N.J., Dec. 3 BIO-key International, Inc. ... public safety and finger-based biometric identification solutions, announced ... Special Shareholder Meeting held today approved the sale ... Mobile Systems Inc. Of the shares voted, 98.6% ...
(Date:12/3/2009)... panels that repels grime and dirt? Expanded battery storage ... University research, just published in Nature Nanotechnology , ... level that could make these futuristic visions come true ... range of 100 nanometers (roughly one-billionth of a meter) ...
(Date:12/3/2009)... 3, 2009) Van Andel Research Institute (VARI) ... (ABA) works at the molecular level to help plants respond ... findings, published in the journal Nature , could help ... and combat global food shortages. The findings could also ...
Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3A window that washes itself? 2VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Regence Employees Give Nearly 241 3 Million to Charity in Two Week Period 61674 1Regence Employees Give Nearly 241 3 Million to Charity in Two Week Period 61674 2GettingHired Announces Additional Funding for Continued Growth as Well as R 26amp 3BD of New Product for Long Term Disability and Workers Comp 61669 1GettingHired Announces Additional Funding for Continued Growth as Well as R 26amp 3BD of New Product for Long Term Disability and Workers Comp 61669 2GettingHired Announces Additional Funding for Continued Growth as Well as R 26amp 3BD of New Product for Long Term Disability and Workers Comp 61669 3IPC The Hospitalist Company Acquires Two New England Practices 61664 1IPC The Hospitalist Company Acquires Two New England Practices 61664 2
... of transgenic crops are the focus of numerous ... journal PloS ONE, which was carried out by ... of Ted Turlings, professor in chemical ecology at ... most transgenic maize lines were significantly more susceptible ...
... 29, 2007 Capuchin monkeys are playful, inquisitive primates ... cognitive abilities. New research now shows that just ... the organization of the brain, specifically in the corpus ... , A recently published paper by Associate ...
... are continuously happening in hospitals. One of these stories ... the World Journal of Gastroenterology because of its shining ... comfort to many families. , It is about a ... Nagasaki University Hospital, Japan in 2004. This patient was ...
Other Biology News:Transgenic maize is more susceptible to aphids 2Influence of sex and handedness on brain is similar in capuchin monkeys and humans 2Clearance of hepatitis C viral infection after liver transplantation 2
(Date:12/2/2009)... announced data presentations on its novel oral JAK2 inhibitor, ... Meeting and Exposition in New Orleans. ,, Data will ... 1 dose-escalation trial of SB1518 detailing its safety, tolerability ... 100 to 600 mg. These doses were administered once ...
(Date:12/2/2009)... /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,("Simcere" or the "Company") ... company,specializing in the development, manufacturing, and marketing of ... that 105 of,its drugs have been included in ... by China,s Ministry of Human Resources and Social,Security ...
(Date:12/2/2009)... -- The world is going through,extraordinary times; markets are ... industries. It turns out that the pharma industry has ... take a,vacation. , During the ... Johnson & Johnson inaugurated an R&D center in Shanghai, ...
(Date:12/2/2009)... Dec. 2 According to the National Institute of Health, ... already have some stage of diabetic retinopathy. Diabetic retinopathy, ... a major cause of blindness in people with diabetes and ... fact, up to 80 percent of all patients who,ve had ...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4
... synthesis inhibitor provides additional treatment option for asthma patients ... ... medications, NAPA, Calif., Sept. 27 Dey, L.P., an,affiliate ... ZYFLO CR(TM) (zileuton) extended-release tablets with its,marketing partner, Critical Therapeutics, Inc. ...
... ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ), ... commercializing proprietary product candidates for the treatment,of ... data from,preclinical studies of ANX-514 (docetaxel emulsion) ... Cancer Research (AACR), National Cancer,Institute (NCI) and ...
... The National,Alliance for Thrombosis and Thrombophilia (NATT) today announced ... that will serve as,building blocks for its efforts to ... one million Americans who develop a blood clot. ... and Prevention (CDC),grants to "launch a national wake-up call ...
Other Biology Technology:Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma 2Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma 3ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference 2ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference 3ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference 4CDC Awards NATT Funding to Improve Blood Clot Awareness 2CDC Awards NATT Funding to Improve Blood Clot Awareness 3
Co-precipitant is free of background polynucleotides,Dnases,Rnases, proteases. 20mg/ml...
Can be used for the quantitative recovery of small amounts of nucleic acids within dilute solutions. 5mg/ml...
RAB32, member RAS oncogene family, mRNA (cDNA clone MGC:13500 IMAGE:4280407), complete cds...
Can be used for the quantitative recovery of small amounts of nucleic acids within dilute solutions. 5mg/ml...
Biology Products: